Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-08-01

Clinical Trial Update: Guanfacine to Treat Borderline Personality Disorder [NA]

View source ↗

Summary

This entry reports a clinical trial investigating guanfacine for Borderline Personality Disorder, conducted by Icahn School of Medicine at Mount Sinai; the curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Borderline Personality Disorder | NA | Status: UNKNOWN